BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 11607824)

  • 1. Biology of EWS/ETS fusions in Ewing's family tumors.
    Arvand A; Denny CT
    Oncogene; 2001 Sep; 20(40):5747-54. PubMed ID: 11607824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1.
    Jeon IS; Davis JN; Braun BS; Sublett JE; Roussel MF; Denny CT; Shapiro DN
    Oncogene; 1995 Mar; 10(6):1229-34. PubMed ID: 7700648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EWS/ETS fusion genes induce epithelial and neuroectodermal differentiation in NIH 3T3 fibroblasts.
    Teitell MA; Thompson AD; Sorensen PH; Shimada H; Triche TJ; Denny CT
    Lab Invest; 1999 Dec; 79(12):1535-43. PubMed ID: 10616204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The EWS protein is dispensable for Ewing tumor growth.
    Kovar H; Jug G; Hattinger C; Spahn L; Aryee DN; Ambros PF; Zoubek A; Gadner H
    Cancer Res; 2001 Aug; 61(16):5992-7. PubMed ID: 11507040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells.
    Tanaka K; Iwakuma T; Harimaya K; Sato H; Iwamoto Y
    J Clin Invest; 1997 Jan; 99(2):239-47. PubMed ID: 9005992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Ewing's sarcoma research: where are we now and what lies ahead?
    Ordóñez JL; Osuna D; Herrero D; de Alava E; Madoz-Gúrpide J
    Cancer Res; 2009 Sep; 69(18):7140-50. PubMed ID: 19738075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
    Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
    Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FUS/ERG gene fusions in Ewing's tumors.
    Shing DC; McMullan DJ; Roberts P; Smith K; Chin SF; Nicholson J; Tillman RM; Ramani P; Cullinane C; Coleman N
    Cancer Res; 2003 Aug; 63(15):4568-76. PubMed ID: 12907633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new member of the ETS family fused to EWS in Ewing tumors.
    Peter M; Couturier J; Pacquement H; Michon J; Thomas G; Magdelenat H; Delattre O
    Oncogene; 1997 Mar; 14(10):1159-64. PubMed ID: 9121764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EWS/ETS fusions activate telomerase in Ewing's tumors.
    Takahashi A; Higashino F; Aoyagi M; Yoshida K; Itoh M; Kyo S; Ohno T; Taira T; Ariga H; Nakajima K; Hatta M; Kobayashi M; Sano H; Kohgo T; Shindoh M
    Cancer Res; 2003 Dec; 63(23):8338-44. PubMed ID: 14678994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts.
    Ouchida M; Ohno T; Fujimura Y; Rao VN; Reddy ES
    Oncogene; 1995 Sep; 11(6):1049-54. PubMed ID: 7566963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.
    Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL
    Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent Ewing's sarcoma EWS/ETS fusions confer a common tumorigenic phenotype on NIH3T3 cells.
    Thompson AD; Teitell MA; Arvand A; Denny CT
    Oncogene; 1999 Sep; 18(40):5506-13. PubMed ID: 10523827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.
    García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J
    Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma.
    Fukuma M; Okita H; Hata J; Umezawa A
    Oncogene; 2003 Jan; 22(1):1-9. PubMed ID: 12527902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors.
    Nishimori H; Sasaki Y; Yoshida K; Irifune H; Zembutsu H; Tanaka T; Aoyama T; Hosaka T; Kawaguchi S; Wada T; Hata J; Toguchida J; Nakamura Y; Tokino T
    Oncogene; 2002 Nov; 21(54):8302-9. PubMed ID: 12447693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Context matters: the hen or egg problem in Ewing's sarcoma.
    Kovar H
    Semin Cancer Biol; 2005 Jun; 15(3):189-96. PubMed ID: 15826833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EWS-ERG fusion transcript produced by chromosomal insertion in a Ewing sarcoma.
    Kaneko Y; Kobayashi H; Handa M; Satake N; Maseki N
    Genes Chromosomes Cancer; 1997 Mar; 18(3):228-31. PubMed ID: 9071576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of the EWS IQ domain regulates transcriptional activity of the EWS/ATF1 and EWS/FLI1 fusion proteins.
    Olsen RJ; Hinrichs SH
    Oncogene; 2001 Mar; 20(14):1756-64. PubMed ID: 11313922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EWS/ETS proteins promote expression and regulate function of the homeodomain transcription factor BRN3A.
    Gascoyne DM; Dunne J; Behjati S; Sebire NJ; Anderson J; Latchman DS
    Oncogene; 2010 May; 29(21):3134-45. PubMed ID: 20348952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.